Among controls, we found that elevated IgA levels against the investigated 5 antigens were not randomly distributed but concentrated on a subgroup of 28.4% (n = 19)—with particular high levels in a subgroup of 4.5% (n = 3), which comprised the progressor from latent infection to active TB. Here, CD79A is linked to disease arising from reactivation of latent virus.